Shp2 activates fyn and ras to regulate RBL-2H3 mast cell activation following FcεRI aggregation

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Fang, Xiaoyun ^a   Lang, Yongjiang ^a   Wang, Yuxiong ^a   Mo, Wei ^a   Wei, Huanhuan ^a   Xie, Jianhui ^a   Yu, Min ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PAXILLIN; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE FYN; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL ACTIVATION; CELL STRAIN RBL 2H3; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PLASMID; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CELL DEGRANULATION; GENE KNOCKDOWN TECHNIQUES; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTO-ONCOGENE PROTEINS C-FYN; RAS PROTEINS; RATS; RECEPTORS, IGE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84863681700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040566     Document Type: Article

References (53)

1. Kraft S, Novak N, (2006) Fc receptors as determinants of allergic reactions. Trends Immunol 27: 88-95.
2. Kinet JP, (1999) The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 17: 931-972.
3. Eiseman E, Bolen JB, (1992) Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 355: 78-80.
4. Furumoto Y, Gomez G, Gonzalez-Espinosa C, Kovarova M, Odom S, et al. (2005) The role of Src family kinases in mast cell effector function. Novartis Foundation symposium 271: 39-47; discussion 47-53, 95-39.
5. Costello PS, Turner M, Walters AE, Cunningham CN, Bauer PH, et al. (1996) Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 13: 2595-2605.
6. Jouvin MH, Adamczewski M, Numerof R, Letourneur O, Valle A, et al. (1994) Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. J Biol Chem 269: 5918-5925.
7. Parravicini V, Gadina M, Kovarova M, Odom S, Gonzalez-Espinosa C, et al. (2002) Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 3: 741-748.
8. Hong H, Kitaura J, Xiao W, Horejsi V, Ra C, et al. (2007) The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood 110: 2511-2519.
9. Odom S, Gomez G, Kovarova M, Furumoto Y, Ryan JJ, et al. (2004) Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med 199: 1491-1502.
10. Saitoh S, Arudchandran R, Manetz TS, Zhang WG, Sommers CL, et al. (2000) LAT is essential for Fc epsilon RI-mediated mast cell activation. Immunity 12: 525-535.
11. Scharenberg AM, El-Hillal O, Fruman DA, Beitz LO, Li Z, et al. (1998) Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. Embo J 17: 1961-1972.
12. Gu HH, Saito K, Klaman LD, Shen JQ, Fleming T, et al. (2001) Essential role for Gab2 in the allergic response. Nature 412: 186-190.
13. Yu M, Lowell CA, Neel BG, Gu H, (2006) Scaffolding adapter Grb2-associated binder 2 requires Syk to transmit signals from FcepsilonRI. J Immunol 176: 2421-2429.
14. Nishida K, Yamasaki S, Hasegawa A, Iwamatsu A, Koseki H, et al. (2011) Gab2, via PI-3K, regulates ARF1 in FcepsilonRI-mediated granule translocation and mast cell degranulation. J Immunol 187: 932-941.
15. Wu CJ, O'Rourke DM, Feng GS, Johnson GR, Wang Q, et al. (2001) The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene 20: 6018-6025.
16. Kambayashi T, Koretzky GA, (2007) Proximal signaling events in Fc epsilon RI-mediated mast cell activation. J Allergy Clin Immunol 119: 544-552; quiz 553-544.
17. Kambayashi T, Larosa DF, Silverman MA, Koretzky GA, (2009) Cooperation of adapter molecules in proximal signaling cascades during allergic inflammation. Immunol Rev 232: 99-114.
18. Zhang J, Berenstein E, Siraganian RP, (2002) Phosphorylation of Tyr342 in the linker region of Syk is critical for Fc epsilon RI signaling in mast cells. Mol Cell Biol 22: 8144-8154.
19. Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, et al. (2000) Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404: 999-1003.
20. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, et al. (2004) Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell 13: 341-355.
21. Saxton TM, Henkemeyer M, Gasca S, Shen R, Rossi DJ, et al. (1997) Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. Embo Journal 16: 2352-2364.
22. Tang TL, Freeman RM Jr, O'Reilly AM, Neel BG, Sokol SY, (1995) The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 80: 473-483.
23. Araki T, Chan G, Newbigging S, Morikawa L, Bronson RT, et al. (2009) Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation. Proc Natl Acad Sci U S A 106: 4736-4741.
24. Binder G, (2009) Noonan syndrome, the Ras-MAPK signalling pathway and short stature. Horm Res 71: 64-70.
25. Zhang W, Chan RJ, Chen H, Yang Z, He Y, et al. (2009) Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia. J Biol Chem 284: 22353-22363.
26. Oh ES, Gu H, Saxton TM, Timms JF, Hausdorff S, et al. (1999) Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2. Mol Cell Biol 19: 3205-3215.
27. Dance M, Montagner A, Salles JP, Yart A, Raynal P, (2008) The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway. Cell Signal 20: 453-459.
28. Tang H, Zhao ZJ, Huang XY, Landon EJ, Inagami T, (1999) Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells. J Biol Chem 274: 12401-12407.
29. Yu M, Luo J, Yang W, Wang Y, Mizuki M, et al. (2006) The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J Biol Chem 281: 28615-28626.
30. Samayawardhena L, Hu J, Stein P, Craig A, (2006) Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor. Cell Signal 18: 1447-1454.
31. McPherson VA, Sharma N, Everingham S, Smith J, Zhu HH, et al. (2009) SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells. J Immunol 183: 4940-4947.
32. Ohtake H, Ichikawa N, Okada M, Yamashita T, (2002) Cutting Edge: Transmembrane phosphoprotein Csk-binding protein/phosphoprotein associated with glycosphingolipid-enriched microdomains as a negative feedback regulator of mast cell signaling through the FcepsilonRI. J Immunol 168: 2087-2090.
33. Hundley TR, Gilfillan AM, Tkaczyk C, Andrade MV, Metcalfe DD, et al. (2004) Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104: 2410-2417.
34. Qiao H, Andrade MV, Lisboa FA, Morgan K, Beaven MA, (2006) FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107: 610-618.
35. Qu CK, Nguyen S, Chen J, Feng GS, (2001) Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood 97: 911-914.
36. Yang W, Klaman LD, Chen B, Araki T, Harada H, et al. (2006) An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev Cell 10: 317-327.
37. Li L, Modi H, McDonald T, Rossi J, Yee JK, et al. (2011) A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells. Blood 118: 1504-1515.
38. Futami M, Zhu QS, Whichard ZL, Xia L, Ke YH, et al. (2011) G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase. Blood 118: 1077-1086.
39. Mohi MG, Neel BG, (2007) The role of Shp2 (PTPN11) in cancer. Curr Opin Genet Dev 17: 23-30.
40. Bard-Chapeau EA, Li S, Ding J, Zhang SS, Zhu HH, et al. (2011) Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell 19: 629-639.
41. Xu R, Yu Y, Zheng S, Zhao X, Dong Q, et al. (2005) Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia. Blood 106: 3142-3149.
42. Gomez G, Gonzalez-Espinosa C, Odom S, Baez G, Cid ME, et al. (2005) Impaired FcepsilonRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J Immunol 175: 7602-7610.
43. Falasca M, Logan SK, Lehto VP, Baccante G, Lemmon MA, et al. (1998) Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. Embo J 17: 414-422.
44. Neel BG, Gu H, Pao L, (2003) The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28: 284-293.
45. Cunnick JM, Meng S, Ren Y, Desponts C, Wang HG, et al. (2002) Regulation of the mitogen-activated protein kinase signaling pathway by SHP2. J Biol Chem 277: 9498-9504.
46. Araki T, Nawa H, Neel BG, (2003) Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J Biol Chem 278: 41677-41684.
47. Agazie YM, Hayman MJ, (2003) Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. Mol Cell Biol 23: 7875-7886.
48. Hanafusa H, Torii S, Yasunaga T, Matsumoto K, Nishida E, (2004) Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty. J Biol Chem 279: 22992-22995.
49. Pan Y, Carbe C, Powers A, Feng GS, Zhang X, (2010) Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development. Development 137: 1085-1093.
50. Barsumian EL, Isersky C, Petrino MG, Siraganian RP, (1981) IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur J Immunol 11: 317-323.
51. Morita S, Kojima T, Kitamura T, (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063-1066.
52. Barnard D, Diaz B, Clawson D, Marshall M, (1998) Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms. Oncogene 17: 1539-1547.
53. Naal RMZG, Tabb J, Holowka D, Baird B, (2004) In situ measurement of degranulation as a biosensor based on RBL-2H3 mast cells. Biosens Bioelectron 20: 791-796.